Stocks › GH
Guardant Health, Inc.
GH·Nasdaq·
United States·USD
$145.83
+0.24 (+0.16%)
Close · Nov 20, 2026 · Close Prices from Tiingo.com
GH
Guardant Health, Inc. · Nasdaq
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
GHS&P 500 (rebased)
Congress BuyCongress SellInsider BuyInsider SellForm 1448-K ResultsLobbying
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair
Congressional Trades
Recent trades of GH by members of U.S. Congress · 12 on record · 2 in the last 12 months
Whale Activity
Position changes in GH reported for 2026-09-30 by 736 institutional filers
- Increased244
- New132
- Held71
- Decreased201
- Closed59
- No prior filing29
| Filer | Shares | Value | Change |
|---|---|---|---|
| BlackRock, Inc. | 8.0M | $1.43B | increased |
| FMR LLC | 7.3M | $1.31B | increased |
| VANGUARD CAPITAL MANAGEMENT LLC | 5.8M | $1.04B | increased |
| PRICE T ROWE ASSOCIATES INC /MD/ | 5.7M | $1.02B | decreased |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 5.3M | $951.6M | decreased |
| FRANKLIN TEMPLETON INC | 3.4M | $571.8M | increased |
| TWO SIGMA INVESTMENTS, LP | 3.1M | $546.4M | decreased |
| Invesco Ltd. | 3.0M | $530.5M | decreased |
| Capital International Investors | 2.9M | $523.8M | decreased |
| Deep Track Capital, LP | 2.8M | $500.4M | decreased |
| GOLDMAN SACHS GROUP INC | 2.8M | $499.4M | decreased |
| AMERIPRISE FINANCIAL INC | 2.7M | $474.7M | — |
Every 13F filer's complete reported book, every quarter since 2013-06-30. 13F itself excludes short positions, cash and most options.
Insider Trading
Net shares bought (+) or sold (−) on the open market by GH insiders, by quarter · Form 4
Recent Insider Transactions
2,168 transactions on record · newest first
| Insider | Type | Shares | Price | Value | Date | |
|---|---|---|---|---|---|---|
| Monroe Terilyn J.Chief People Officer | Sale | −704 | $143.64 | $101K | Nov 18, 2026 | Form 4 ↗ |
| Monroe Terilyn J.Chief People Officer | Sale | −500 | $140.64 | $70K | Nov 18, 2026 | Form 4 ↗ |
| Monroe Terilyn J.Chief People Officer | Sale | −1,338 | $142.83 | $191K | Nov 18, 2026 | Form 4 ↗ |
| Monroe Terilyn J.Chief People Officer | Sale | −1,200 | $141.79 | $170K | Nov 18, 2026 | Form 4 ↗ |
| Monroe Terilyn J.Chief People Officer | Sale | −100 | $144.58 | $14K | Nov 18, 2026 | Form 4 ↗ |
| Tariq MusaDirector · Director | Sale | −116 | $149.56 | $17K | Nov 16, 2026 | Form 4 ↗ |
| Azar Alex M IIDirector · Director | Sale | −69 | $149.56 | $10K | Nov 16, 2026 | Form 4 ↗ |
| Tariq MusaDirector · Director | Sale | −116 | $165.88 | $19K | Oct 16, 2026 | Form 4 ↗ |
| Azar Alex M IIDirector · Director | Sale | −69 | $159.89 | $11K | Oct 14, 2026 | Form 4 ↗ |
| MIGNONE ROBERTODirector | Option exercise | +264 | $0.00 | $0 | Sep 21, 2026 | Form 4 ↗ |
| Hidalgo Medina ManuelDirector | Option exercise | +232 | $0.00 | $0 | Sep 17, 2026 | Form 4 ↗ |
| Tariq MusaDirector | Sale | −116 | $175.00 | $20K | Sep 16, 2026 | Form 4 ↗ |
| Krognes Steve E.Director | Sale | −971 | $177.48 | $172K | Sep 16, 2026 | Form 4 ↗ |
| Krognes Steve E.Director | Sale | −1,300 | $176.34 | $229K | Sep 16, 2026 | Form 4 ↗ |
| Krognes Steve E.Director | Sale | −3,300 | $175.42 | $579K | Sep 16, 2026 | Form 4 ↗ |
| Krognes Steve E.Director | Sale | −1,103 | $174.46 | $192K | Sep 16, 2026 | Form 4 ↗ |
| Azar Alex M IIDirector | Sale | −826 | $175.00 | $145K | Sep 16, 2026 | Form 4 ↗ |
| Chudova DaryaChief Technology Officer | Sale | −7,738 | $178.00 | $1.4M | Sep 15, 2026 | Form 4 ↗ |
| Tariq MusaDirector | Option exercise | +249 | $0.00 | $0 | Sep 15, 2026 | Form 4 ↗ |
| Azar Alex M IIDirector | Option exercise | +1,651 | $0.00 | $0 | Sep 12, 2026 | Form 4 ↗ |
Fund Holders
Mutual funds and ETFs holding GH · SEC Form N-PORT
| Fund | Shares | Value | % of fund | As of |
|---|---|---|---|---|
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 4.0M | $600.1M | 0.03% | Jun 30, 2026 |
| VANGUARD SMALL-CAP INDEX FUND VANGUARD INDEX FUNDS | 2.9M | $433.4M | 0.23% | Jun 30, 2026 |
| T. Rowe Price New Horizons Fund, Inc. | 1.8M | $266.8M | 1.81% | Jun 30, 2026 |
| Franklin Dynatech Fund Franklin Custodian Funds | 1.8M | $262.6M | 0.87% | Jun 30, 2026 |
| FULLERTHALER BEHAVIORAL SMALL-CAP GROWTH Capitol Series Trust | 1.7M | $259.5M | 4.20% | Jun 30, 2026 |
| VANGUARD SMALL-CAP GROWTH INDEX FUND VANGUARD INDEX FUNDS | 1.7M | $249.9M | 0.53% | Jun 30, 2026 |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 1.5M | $228.1M | 0.23% | Jun 30, 2026 |
| Eventide Gilead Fund MUTUAL FUND SERIES TRUST | 1.3M | $189.8M | 5.52% | Jun 30, 2026 |
| Growth Fund of America | 1.1M | $177.3M | 0.05% | Aug 31, 2026 |
| Invesco Discovery Fund AIM Counselor Series Trust (Invesco Counselor Series Trust) | 975.6K | $155.1M | 2.09% | Aug 31, 2026 |
Mutual funds and ETFs whose N-PORT filings list GH's shares (CUSIP 40131M109), each fund at its latest report since Apr 21, 2026, largest positions first. Bonds, options and short positions are left out.
Activist & Passive Stakes
Schedule 13D / 13G beneficial-ownership filings
- Abigail P. JohnsonSCHEDULE 13G · passive (13G) · 7.7M shares5.8%
Nov 5, 2026 · ↗ - FMR LLCSCHEDULE 13G · passive (13G) · 7.7M shares5.8%
Nov 5, 2026 · ↗ - T. Rowe Price Associates, Inc.SCHEDULE 13G/A · passive (13G) · 6.5M shares4.9%
Aug 14, 2026 · ↗ - BlackRock, Inc.SCHEDULE 13G/A · passive (13G) · 6.9M shares5.2%
Jul 28, 2026 · ↗ - T. Rowe Price Associates, Inc.SCHEDULE 13G · passive (13G) · 7.0M shares5.4%
May 15, 2026 · ↗ - Vanguard Capital ManagementSCHEDULE 13G · passive (13G) · 6.6M shares5.0%
Apr 30, 2026 · ↗
Corporate Lobbying
Estimated quarterly lobbying spending reported under the LDA, filings naming guardant health as client
- TODD STRATEGY GROUPGUARDANT HEALTH, INC. · 2026 Q2 · HCR$80K
Filing ↗ - GUARDANT HEALTHGUARDANT HEALTH · 2026 Q3 · MMM, HCR$180K
Filing ↗ - IPOLICY SOLUTIONSGUARDANT HEALTH INC. · 2026 Q3 · MMM, MED$16K
Filing ↗ - TODD STRATEGY GROUPGUARDANT HEALTH, INC. · 2026 Q2 · HCR$80K
Filing ↗ - GUARDANT HEALTHGUARDANT HEALTH · 2026 Q2 · MMM, HCR$180K
Filing ↗
Government Contracts
Federal awards to Guardant Health, Inc. · USAspending
No federal contract awards found for Guardant Health, Inc..
U.S. Patents
Recent USPTO applications naming Guardant Health, Inc.
No USPTO patent applications found for Guardant Health, Inc..
Annual Financials
From GH's 10-K filings · XBRL
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $982.0M | $739.0M | $563.9M | $449.5M | $373.7M |
| Operating income | -$437.2M | -$443.6M | -$564.7M | -$544.4M | -$411.0M |
| Net income | -$416.3M | -$436.4M | -$479.4M | -$654.6M | -$384.8M |
| Diluted EPS | -$3.32 | -$3.56 | -$4.28 | -$6.41 | -$4.00 |
| Operating cash flow | -$184.8M | -$239.9M | -$325.0M | -$309.5M | -$209.0M |
| Cash and equivalents | $378.2M | $525.5M | $1.13B | $141.6M | $492.2M |
| Total assets | $2.01B | $1.49B | $1.79B | $1.61B | $2.20B |
| Total liabilities | $2.11B | $1.63B | $1.63B | $1.55B | $1.56B |
| Shareholders' equity | -$99.3M | -$139.6M | $158.7M | $60.2M | $645.0M |
As Guardant Health, Inc. tagged them in its 10-K filings: totals for the year on the income and cash-flow lines, values at the year's end on the balance-sheet lines. Latest 10-K, filed Feb 19, 2026 ↗
Stock Splits
Every split and reverse split in the price history
No stock splits in GH's price history.
Material Events (8-K)
Corporate events filed with the SEC
- 8-K · Items 1.01, 2.03, 3.02, 8.01, 9.01Material agreement · Direct financial obligation · Unregistered sale of equityNov 16, 2026
EDGAR ↗ - 8-K · Items 2.02, 9.01Results of operationsNov 5, 2026
EDGAR ↗ - 8-K · Items 5.02, 9.01Officer / director changeNov 3, 2026
EDGAR ↗ - 8-K · Items 5.02, 9.01Officer / director changeNov 3, 2026
EDGAR ↗ - 8-K · Items 2.02, 9.01Results of operationsJul 30, 2026
EDGAR ↗ - 8-K · Items 5.07Shareholder voteJun 18, 2026
EDGAR ↗ - 8-K · Items 2.02, 9.01Results of operationsMay 7, 2026
EDGAR ↗
About Guardant Health, Inc.
From SEC EDGAR company records
Industry (SIC 8071)Services-Medical Laboratories
SectorHealthcare
HeadquartersPALO ALTO, CA
IncorporatedDE
SEC CIK0001576280 ↗



